Targretin Capsules
- Name:
Targretin Capsules
- Company:
Eisai Ltd
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may not be renewed (A)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 27/02/19
(Click to Download)XPIL
Package leaflet: Information for the user
Package leaflet: Information for the user
1. What Targretin is and what it is used for
1. What Targretin is and what it is used for
2. What you need to know before you take Targretin
2. What you need to know before you take Targretin
3. How to take Targretin
3. How to take Targretin
4. Possible side effects
4. Possible side effects
5. How to store Targretin
5. How to store Targretin
6. Contents of the pack and other information
6. Contents of the pack and other information
Click on this link to Download PDF directly
Eisai Ltd
Company Products
| Medicine Name | Active Ingredients |
|---|---|
| Medicine Name Fycompa 0.5 mg/ml oral suspension | Active Ingredients Perampanel |
| Medicine Name Fycompa tablets | Active Ingredients Perampanel |
| Medicine Name Gliadel | Active Ingredients Carmustine |
| Medicine Name Halaven 0.44 mg/ml solution for injection | Active Ingredients Eribulin mesylate |
| Medicine Name Inovelon Oral Suspension | Active Ingredients Rufinamide |
| Medicine Name Inovelon Tablets | Active Ingredients Rufinamide |
| Medicine Name Lenvima (lenvatinib) | Active Ingredients Lenvatinib mesilate |
| Medicine Name Targretin Capsules | Active Ingredients Bexarotene |
| Medicine Name Zebinix 200mg tablets | Active Ingredients eslicarbazepine acetate |
| Medicine Name Zebinix 50 mg/ml Oral Suspension | Active Ingredients eslicarbazepine acetate |
| Medicine Name Zebinix 800mg tablets | Active Ingredients eslicarbazepine acetate |
| Medicine Name Zonegran capsules | Active Ingredients Zonisamide |
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 27 February 2019 PIL
Reasons for updating
- Change to section 6 - marketing authorisation holder
- Change to section 6 - manufacturer
- Change to section 6 - date of revision
Updated on 26 February 2019 SmPC
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
|
Documented changes |
|
|
Sections of the SmPC |
Changes/updates |
|
Section 7 |
Marketing Authorisation Holder details have been updated: Eisai GmbH Lyoner Straße 36 60528 Frankfurt am Main Germany E-mail: medinfo_de@eisai.net |
|
Section 10 |
The date of revision of text has been updated to 11/2018 |
Updated on 5 July 2018 PIL
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
Updated on 3 July 2018 PIL
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
Updated on 9 May 2018 SmPC
Reasons for updating
- New SmPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 9 May 2018 SmPC
Reasons for updating
- New SmPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 8 May 2018 SmPC
Reasons for updating
- New SmPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 4 May 2018 PIL
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 6 - date of revision
Updated on 3 May 2018 SmPC
Reasons for updating
- New SmPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 30 April 2018 SmPC
Reasons for updating
- New SmPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 30 April 2018 SmPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
|
Documented changes |
|
|
Sections of the SmPC |
Changes/updates |
|
Section 4.4 |
The following text has been added: Psychiatric disorders |
|
Section 4.8 |
Change to the formating of the tabulated adverse events |
|
Section 10 |
Date of revision updated to 22 March 2018 |
Updated on 28 November 2017 PIL
Reasons for updating
- New PIL for new product
Updated on 28 November 2017 PIL
Reasons for updating
- Change to MA holder contact details
- Improved presentation of PIL
- Change to section 6 - date of revision
Updated on 10 September 2015 PIL
Reasons for updating
- Change to date of revision
- Change to MA holder contact details
Updated on 9 June 2015 SmPC
Reasons for updating
- New SmPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 3 June 2015 PIL
Reasons for updating
- Change to drug interactions
- Change to date of revision
Updated on 25 June 2012 PIL
Reasons for updating
- New PIL for medicines.ie
- PIL Submitted in error